Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Sohere we go again
Craving scores were significantly lower in the GLP-1RA group compared to the control group, as evidenced by a significant main effect of group ( 2 (1) = 4.71, p = 0.03, f = 0.58
Randlov, J
Well be returning to the 3rd episode of the Patient Mailbox series next week with Dr Peter Chng, so remember to check it out next week
StatPearls Publishing, Treasure Island Brandfon S et al (2023) Advances in anti-obesity pharmacotherapy: current treatments, emerging therapies, and challenges
US$ 23.34
US$ 25.92
US$ 27.24
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 23.81
